Ocugen Inc (OCGN)
2.24
+0.01 (+0.45%)
USD |
NASDAQ |
May 23, 14:33
Ocugen Total Assets (Quarterly): 141.73M for March 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2022 | 141.73M |
December 31, 2021 | 105.76M |
September 30, 2021 | 116.31M |
June 30, 2021 | 124.25M |
March 31, 2021 | 53.85M |
December 31, 2020 | 27.38M |
September 30, 2020 | 20.54M |
June 30, 2020 | 23.76M |
March 31, 2020 | 12.31M |
December 31, 2019 | 16.81M |
September 30, 2019 | 23.62M |
June 30, 2019 | 3.20M |
March 31, 2019 | 14.84M |
December 31, 2018 | 17.43M |
September 30, 2018 | 10.88M |
June 30, 2018 | 15.15M |
March 31, 2018 | 21.32M |
Date | Value |
---|---|
December 31, 2017 | 11.04M |
September 30, 2017 | 15.83M |
June 30, 2017 | 22.13M |
March 31, 2017 | 28.31M |
December 31, 2016 | 36.08M |
September 30, 2016 | 42.80M |
June 30, 2016 | 21.28M |
March 31, 2016 | 28.52M |
December 31, 2015 | 36.79M |
September 30, 2015 | 45.30M |
June 30, 2015 | 53.24M |
March 31, 2015 | 61.58M |
December 31, 2014 | 65.50M |
September 30, 2014 | 13.00M |
June 30, 2014 | 14.84M |
December 31, 2013 | 14.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.20M
Minimum
Jun 2019
141.73M
Maximum
Mar 2022
39.91M
Average
20.93M
Median
Total Assets (Quarterly) Benchmarks
Immunogen Inc | 481.71M |
Intercept Pharmaceuticals Inc | 503.36M |
Karyopharm Therapeutics Inc | 294.03M |
Voyager Therapeutics Inc | 224.18M |
Moderna Inc | 27.61B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 10.60M |
Shareholders Equity (Quarterly) | 131.13M |